Neuronal Ceroid Lipofuscinosis Enzyme CLN2




Test Mnemonic

CLN2

CPT Codes

  • 82657 - QTY (1)

Aliases

  • Tripeptidylpeptidase

Performing Laboratory

Seattle Children's Hospital


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
N/ABloodSee note AmbientDried blood spots on filter paper (newborn screening card); 2 full circles

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
10 mLWhole bloodACD A or B (Yellow) AmbientCollect Monday - Thursday only. Specimen MUST arrive at Cleveland Clinic Laboratories before 3:00 p.m. on the day of collection. Do not spin.
TwoFibroblasts, culturedT25 flask AmbientTwo T-25 cultured fibroblast flasks
10 mLWhole bloodSodium heparin (Green) AmbientCollect Monday - Thursday only. Specimen MUST arrive at Cleveland Clinic Laboratories before 3:00 p.m. on the day of collection. Do not spin.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
6 mL    Whole blood

Stability

Environmental Condition Description
Ambient24 hours
FrozenUnacceptable
Refrigerated24 hours

Days Performed

Varies (one day/week)

Turnaround Time

8 - 11 days

Methodology

Name Description
Fluorometric enzyme assay 

Reference Range

Special Info

For prenatal samples, maternal cell contamination testing is required. This must be ordered separately.

Clinical Info

Approximately 80% of patients with late infantile Neuronal Ceroid Lipofuscinosis (NCL) and 7% of patients with juvenile onset NCL have a deficiency of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1). The disease is characterized by seizures, ataxia, myoclonus, psychomotor retardation, speech impairment, and vision loss.